Cold Chain Technologies (CCT) announced plans to launch MedAssure, its new cold chain orchestration platform.
“In the face of an increasingly volatile global cold chain, pharmaceutical companies need more than reactive cold chain management, they need a strategic, end‑to‑end system that anticipates risk, optimizes performance and ensures product integrity. In other words, they need thermal assurance,” says Paul Della Villa, director, digital solutions and services at Cold Chain Technologies. “MedAssure, unlike generic visibility platforms, combines purpose-built technology with hands-on technical partnership, product design and diverse supply models. This fusion of technology, packaging supply, insight, and support enables customers to optimize their supply chain design and digitize their unique operational risks in a way that visibility alone cannot.”
Key takeaways:
· MedAssure provides proactive data-driven intelligence designed to support reductions in risk, cost and environmental footprint.
· This latest development represents a key addition to its thermal assurance ecosystem, which integrates best-in-class product solutions with emerging and established technology and human expertise for end-to-end resilience.
